Exosomes from Muse MSC Stem Cells, Derived from Placenta (Wharton’s Jelly) – 100 Billion

What are Exosomes?

Exosomes are extracellular vesicles generated by cells, carrying nucleic acids, proteins, lipids, and metabolites. They mediate both short- and long-range intercellular communication in health and disease, influencing various aspects of cellular biology.

Exosomes are membrane-bound extracellular vesicles that vary in diameter. Research has shown that exosomes are secreted by most cell types, including immune cells (B cells, T cells, mast cells, dendritic cells), neuronal cells, epithelial cells, endothelial cells, embryonic cells, cancer cells, and mesenchymal stem cells (MSCs).

The term “extracellular vesicle (EV)” broadly encompasses several types of vesicles, including exosomes, microvesicles, and apoptotic bodies. However, the term “exosome” specifically refers to vesicles that are formed within multivesicular bodies (MVBs).

Exosomes carry vital information and macromolecules from their cell of origin, playing a crucial role in intercellular communication. These macromolecules include various proteins, enzymes, transcription factors, lipids, extracellular matrix proteins, receptors, and nucleic acids.

Our focus is the production of a pharmaceutical-grade exosome preparation for personalized therapy, compliant with European Regulation No. 726/2004 and Directive No. 2001/83/EC— Exosomes derived from Muse MSC Stem Cells.

All other exosomes derived from blood cells, other cell types, or human fluids have no relevance to regenerative medicine and do not contribute to the self-renewal process. Instead, they carry only laboratory data about ongoing biological processes within the living organism.

Patients should seek treatment with exosomes derived from stem cells, rather than exosomes of unknown origin, to achieve a real therapeutic effect.

The application of exosome therapy is prescribed by a physician and can be administered intravenously, intramuscularly, or subcutaneously. The treatment goals and protocols are determined at the discretion of the treating physician.

What is the stem cell secretome?

In scientific terms, the secretome refers to the collection of all substances secreted by stem cells into the extracellular environment. This includes microvesicles, exosomes, proteins, cytokines (cellular messengers), hormone-like substances, and immunomodulatory factors.

Modern research suggests that the effects of stem cells observed in clinical trials are not solely due to the cells themselves but also to the vesicles, protein molecules, and other bioactive compounds such as cytokines that they release. These substances, secreted into the extracellular space, are collectively referred to as the secretome, as the process of their release is known as secretion. However, which specific components of the secretome drive the actual therapeutic effects remains largely unknown.Our exosomes are derived from donor-derived Muse MSC (mesenchymal stem cells).

Exosomes, averaging 50–100 nanometers in diameter, are a subgroup of extracellular vesicles (EVs). The biogenesis of exosomes begins in endosomes, where interactions with other intracellular vesicles and organelles shape their final molecular composition. Their diverse contents include nucleic acids, proteins, lipids, amino acids, and metabolites, which often reflect their cellular origin.

Exosomes derived from mesenchymal stem cells (MSCs) have demonstrated therapeutic benefits comparable to cell therapy, particularly in regenerative and neovascularization processes, as well as in their anti-apoptotic, anti-remodeling, and anti-inflammatory effects. Compared to their parent cells, exosomes offer several advantages, including lower immunogenicity and the absence of tumor formation risk. Recently, new strategies have been developed to enhance the efficacy and stability of exosome-based therapies. These include preconditioning exosomes before transplantation, utilizing MSC-derived exosome extracts, and employing exosomes as targeted drug delivery systems.

Exosomes derived from mesenchymal stem cells (MSCs) exhibit immunomodulatory and anti-inflammatory effects, which help reduce neural tissue damage. The immunomodulatory effects of MSC-derived exosomes are primarily attributed to the interaction of exosomal miRNAs. These exosomes are capable of transforming macrophages from M0 and M1 phenotypes into the M2 phenotype, which is associated with tissue repair and anti-inflammatory responses. Additionally, MSC-derived exosomes increase the secretion of M2-associated cytokines, such as TGF-β and IL-10, while reducing the levels of M1-associated cytokines, including IL-6, IL-12, and TNF-α.

Over the past few decades, exosomes derived from mesenchymal stem cells (MSC-Exs) have gained significant attention as a therapeutic tool in regenerative medicine. Exosomes are a type of extracellular vesicles (EVs) that play a crucial role in cell-to-cell communication through various processes, including stress response, aging, angiogenesis, cellular differentiation, and signaling.

In summary, MSC - Exosomes can serve as an intelligent drug delivery approach by transporting exogenous chemicals and biomolecules for regenerative medicine, even without the use of stem cells.

MSC - Exosomes have many potential therapeutic advantages compared to synthetic nanoparticles, liposomes, single molecules, and cells. These advantages arise from their unique beneficial properties, such as smaller size, lower complexity, lack of a nucleus (thus preventing neoplastic transformation), enhanced stability, easier production, longer storage, and the potential to be loaded with proteins, small molecules, or RNA for biomolecule delivery.

MSC - Exosomes can also be modified to display various antibodies or surface receptors, facilitating the targeted transfer of therapeutic payloads to specific organs, tissues, and cells. Furthermore, MSC - Exosomes can accommodate multiple types of biological molecules, allowing them to participate in various therapeutic approaches simultaneously, which cannot be achieved with conventional small molecules.

This is why we examine the recent advances in the molecular mechanisms of exosomes in regenerative medicine and exosome research, as well as explore the potential therapeutic applications of exosomes in tissue regeneration following disease recovery, injury, or chronic conditions.

What is exosome therapy?

Exosome therapy involves the use of exosomes—small vesicles—for intravenous, intramuscular, or subcutaneous administration, approved in accordance with European Regulation No. 726/2004 and Directive No. 2001/83/EC.

These exosomes contain a variety of biomolecules, including proteins, nucleic acids, and lipids, which can be used to target specific cells and trigger a desired response. This innovative medical treatment is being explored for various potential applications.

Exosome therapy is gaining increasing popularity, and we are the only provider within the European Union offering the production of medicinal products for personalized treatment, manufactured under European Directive No. 2001/83/EC, specifically for individual patients.

Many medical professionals believe that exosomes hold therapeutic potential, based on research that suggests a link between the health benefits of mesenchymal stem cell (MSC) therapy and exosome-based treatments.

Exosomes are naturally released from mesenchymal stem cells, and MSCs produce the highest quantity of exosomes among all cell types in the human body.

Potential therapeutic applications : 

Stem cells are being researched for their potential use in a wide range of medical treatments, including the repair and regeneration of damaged tissues and organs. Exosomes, on the other hand, are being studied as a delivery system for therapeutic molecules targeting specific cells in the body. They have been proposed as a potential treatment for various conditions, including autoimmune diseases, neurodegenerative disorders, cardiovascular diseases, and many others.

Why is interest in exosome therapy growing?

According to a 2016 study conducted by James R. Edgar and colleagues, an increased interest in exosome therapy can be observed for several reasons : 

Exosomes are believed to provide a means for intercellular communication and the transmission of macromolecules and signals between cells in the human body. 

Exosomes are attributed roles in the distribution of proteins, lipids, mRNA, miRNA, and DNA.

Exosomes are assumed to be useful drug vectors since they are composed of cellular membranes rather than synthetic polymers and, as such, could be tolerated without side effects by the host.

Storage: Short-term: 2-8°C; Long-term: -80°C.